MDR1 expression correlates with mutantp53 expression in colorectal cancer metastases
- 1 November 1996
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 122 (11) , 671-675
- https://doi.org/10.1007/bf01209030
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Region 3′ to the Major Transcriptional Start Site of the MDR1 Downstream Promoter Mediates Activation by a Subset of Mutant P53 ProteinsBiochemical and Biophysical Research Communications, 1995
- P-glycoprotein, HER-2/neu, and Mutant p53 Expression in Human Gynecologic TumorsJNCI Journal of the National Cancer Institute, 1994
- c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.1993
- Position Specificity of Ki-ras Oncogene Mutations during the Progression of Colorectal CarcinomaOncology, 1993
- PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemiaAnnals of Hematology, 1992
- Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53Science, 1992
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicalsCarcinogenesis: Integrative Cancer Research, 1988
- Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences, 1987
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987